Genprex
GNPX
16 hedge funds and large institutions have $2.6M invested in Genprex in 2023 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 3 closing their positions.
0% more funds holding
Funds holding: 16 → 16 (0)
0% more ownership
Funds ownership: 0% → 0% (+0%)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
28% less capital invested
Capital invested by funds: $3.6M → $2.6M (-$1.01M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CH
CVI Holdings
Wilmington,
Delaware
|
+$1.24M |
| 2 |
AE
AMH Equity
Great Neck,
New York
|
+$496K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$27.6K |
| 4 |
VCP
Verus Capital Partners
Scottsdale,
Arizona
|
+$27.6K |
| 5 |
VF
Virtu Financial
New York
|
+$27.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Rockefeller Capital Management
New York
|
-$142K |
| 2 |
Group One Trading
Chicago,
Illinois
|
-$27.6K |
| 3 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$27.6K |
| 4 |
CWM
CCG Wealth Management
San Diego,
California
|
-$14.3K |
| 5 |
HighTower Advisors
Chicago,
Illinois
|
-$12K |
GNPX Hedge Fund Activity: Q3 2023 in Review
16 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Genprex (GNPX) for Q3 2023, worth a combined $2.6M — down 28% from $3.6M a quarter earlier.
Fund positioning in GNPX was balanced in Q3 2023: 3 funds opened new positions, 3 closed out, 2 added to existing stakes and 0 trimmed.
The largest buyer was CVI Holdings, opening a new position worth an estimated $1.24M. The largest seller was Rockefeller Capital Management, exiting entirely with an estimated $142K sold.
- 16 institutional investors held Genprex (GNPX) as of Q3 2023, unchanged from Q2 2023.
- Funds reported $2.6M of Genprex stock for Q3 2023, down 28% quarter-over-quarter.
- 3 funds opened new Genprex positions in Q3 2023 and 3 closed out, a net change of 0 holders.
- The largest Genprex buyer in Q3 2023 was CVI Holdings, an estimated $1.24M added.
- The largest Genprex seller in Q3 2023 was Rockefeller Capital Management, an estimated $142K sold.
Based on aggregated 13F filings for Q3 2023.